Skip to content

Clinical trials

Observational Lung Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Netherlands Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20102
20112
20133
20142
20151
20161
20173
20191
20201
20213
20224
20234
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting10
Unknown status5
Active, not recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht Radiation Oncology7
Radboud University Medical Center4
Maastricht University Medical Center3
Amsterdam UMC, location VUmc2
Creo Medical Limited2
UMC Utrecht2
University Medical Center Groningen2
Academisch Ziekenhuis Maastricht1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms36
Neoplasms7
Prostatic Neoplasms4
Breast Neoplasms3
Colorectal Neoplasms3
Kidney Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Urinary Bladder Neoplasms3
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.